Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? EQUITY (Details Narrative)

v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Feb. 28, 2023
Mar. 31, 2023
Mar. 31, 2022
Subsidiary, Sale of Stock [Line Items]      
Proceeds from issuance initial public offering [1]   $ 94,766
Proceeds from options and warrants exercised   835 69
Number of common shares issued for service, value   132  
Unrecognized stock-based compensation expense   $ 7,632  
Weighted average remaining vesting period   1 year 3 months 14 days  
Warrant [Member]      
Subsidiary, Sale of Stock [Line Items]      
Warrant to purchase of common stock   557,733  
Proceeds from options and warrants exercised   $ 835  
Common Stock [Member]      
Subsidiary, Sale of Stock [Line Items]      
Common stock issued in public offering, shares [2]   8,333,333  
Common Stock [Member] | Board of Directors Chairman [Member]      
Subsidiary, Sale of Stock [Line Items]      
Number of common shares issued for service   5,866  
Stock Options and Warrants [Member]      
Subsidiary, Sale of Stock [Line Items]      
Sharebased compensation expense   $ 7,775 $ 1,962
IPO [Member]      
Subsidiary, Sale of Stock [Line Items]      
Common stock issued in public offering, shares 8,333,333    
Offering price per share $ 12.00    
Gross proceeds from public offering $ 100,000    
Proceeds from issuance initial public offering $ 94,766    
Common stock issued in public offering, additional shares 1,249,999    
[1] Includes gross proceeds of $
[2] Includes gross proceeds of $100,000, less issuance costs of $5,234.